MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517044347 A) filed by Daewoong Pharmaceutical Co. Ltd., Gyeonggi, Republic of Korea, on May 7, for 'controlled release pharmaceutical composition.'
Inventor(s) include Kwon, Seonju; Ha, Songyi; Kim, Gyoung Won; Hwang, On; Kim, Gwan Young; Cho, Sang Eun; Kim, Dongyoon; Park, Min Young; and Choi, Jongwon.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a formulation capable of inhibiting the early release of a specific PRS inhibitor and has the effect of preventing the side effects of nausea or vomiting, which may occur when too much of an active ingredient is absorbed at an early stage."
The patent application was internationally filed on Nov. 10, 2023, under International application No.PCT/KR2023/018035.
Disclaimer: Curated by HT Syndication.
